Immunogenicity Assessment and Management

Ensuring the Safety and Efficacy of Biologics

This year's Immunogenicity & Bioassay Stream focuses on the latest science, technologies and strategies to ensure the safety and efficacy of biologics, with particular focus on novel modalities including cell & gene therapies, bispecifics, trispecifics, immunotherapies and ADCs. Part One dives into bioassay design, development, and analysis through an interactive training seminar. Part Two examines immunogenicity assessment and management including but not limited to: assay development and validation, clinical relevance, the regulatory landscape and recent advances with predictive studies and tools.

Programs Include:

May 11-12

Bioassay Training Seminar Check Back for Additional Details

May 12-13

Immunogenicity Assessment and Management